References
- Guh AY, Mu Y, Winston LG, et al. Trends in US burden of Clostridioides difficile infection and outcomes. N Engl J Med. 2020;382(14):1320–1330.
- Kordus SL, Thomas AK, Lacy DB. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics. Nat Rev Microbiol. 2022;20(5):285–298.
- Schnizlein MK, Young VB. Capturing the environment of the Clostridioides difficile infection cycle. Nat Rev Gastroenterol Hepatol. 2022;19:508–520.
- Smits WK, Lyras D, Lacy DB, et al. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2:16020.
- McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987–994.
- Fatima R, Aziz M. The hypervirulent strain of Clostridium difficile: NAP1/B1/027 – a brief overview. Cureus. 2019;11(1):e3977.
- Majumdar A, Govind R. Regulation of Clostridioides difficile toxin production. Curr Opin Microbiol. 2022;65:95–100.
- Shen A. Clostridioides difficile spore formation and germination: new insights and opportunities for intervention. Annu Rev Microbiol. 2020;74:545–566.
- Castro-Cordova P, Mora-Uribe P, Reyes-Ramirez R, et al. Entry of spores into intestinal epithelial cells contributes to recurrence of Clostridioides difficile infection. Nat Commun. 2021;12(1):1140.
- Gerding DN, Kelly CP, Rahav G, et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence. Clin Infect Dis. 2018;67(5):649–656.
- Chen P, Zeng J, Liu Z, et al. Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection. Nat Commun. 2021;12(1):3748.
- de Bruyn G, Gordon DL, Steiner T, et al. Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial. Lancet Infect Dis. 2021;21(2):252–262.
- Sandhu A, Chopra T. Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls. Therap Adv Gastroenterol. 2021;14. doi:10.1177/17562848211053105.
- Lee CD, Rizvi A, Edwards AN, et al. Genetic mechanisms governing sporulation initiation in Clostridioides difficile. Curr Opin Microbiol. 2021;66:32–38.
- Zhu D, Sorg JA, Sun X. Clostridioides difficile biology: sporulation, germination, and corresponding therapies for C. difficile infection. Front Cell Infect Microbiol. 2018;8:29.
- Paredes-Sabja D, Cid-Rojas F, Pizarro-Guajardo M. Assembly of the exosporium layer in Clostridioides difficile spores. Curr Opin Microbiol. 2022;67:102137.
- Paredes-Sabja D, Shen A, Sorg JA. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol. 2014;22(7):406–416.
- Henriques AO, Moran CP, Jr. Structure, assembly, and function of the spore surface layers. Annu Rev Microbiol. 2007;61:555–588.
- Driks A, Eichenberger P. The spore coat. Microbiol Spectr. 2016;4(2):4.2.03.
- Edwards AN, McBride SM. Initiation of sporulation in Clostridium difficile: a twist on the classic model. FEMS Microbiol Lett. 2014;358(2):110–118.
- Al-Hinai MA, Jones SW, Papoutsakis ET. The clostridium sporulation programs: diversity and preservation of endospore differentiation. Microbiol Mol Biol Rev. 2015;79(1):19–37.
- Tan IS, Ramamurthi KS. Spore formation in Bacillus subtilis. Environ Microbiol Rep. 2014;6(3):212–225.
- McKenney PT, Driks A, Eichenberger P. The Bacillus subtilis endospore: assembly and functions of the multilayered coat. Nat Rev Microbiol. 2013;11(1):33–44.
- Childress KO, Edwards AN, Nawrocki KL, et al. The phosphotransfer protein CD1492 represses sporulation initiation in Clostridium difficile. Infect Immun. 2016;84(12):3434–3444.
- Edwards AN, Wetzel D, DiCandia MA, et al. Three orphan histidine kinases inhibit Clostridioides difficile sporulation. J Bacteriol. 2022;204(5):e0010622.
- Deakin LJ, Clare S, Fagan RP, et al. The Clostridium difficile Spo0A gene is a persistence and transmission factor. Infect Immun. 2012;80(8):2704–2711.
- Pettit LJ, Browne HP, Yu L, et al. Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism. BMC Genomics. 2014;15:160.
- Rosenbusch KE, Bakker D, Kuijper EJ, et al. C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PLoS One. 2012;7(10):e48608.
- Saujet L, Monot M, Dupuy B, et al. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J Bacteriol. 2011;193(13):3186–3196.
- Edwards AN, Tamayo R, McBride SM. A novel regulator controls Clostridium difficile sporulation, motility and toxin production. Mol Microbiol. 2016;100(6):954–971.
- Edwards AN, Anjuwon-Foster BR, McBride SM. RstA is a major regulator of Clostridioides difficile toxin production and motility. mBio. 2019;10(2):e01991-18.
- Edwards AN, Krall EG, McBride SM. Strain-dependent RstA regulation of Clostridioides difficile toxin production and sporulation. J Bacteriol. 2020;202(2):e00586-19.
- Sonenshein AL. CodY, a global regulator of stationary phase and virulence in gram-positive bacteria. Curr Opin Microbiol. 2005;8(2):203–207.
- Shivers RP, Sonenshein AL. Activation of the Bacillus subtilis global regulator CodY by direct interaction with branched-chain amino acids. Mol Microbiol. 2004;53(2):599–611.
- Handke LD, Shivers RP, Sonenshein AL. Interaction of Bacillus subtilis CodY with GTP. J Bacteriol. 2008;190(3):798–806.
- Nawrocki KL, Edwards AN, Daou N, et al. CodY-dependent regulation of sporulation in Clostridium difficile. J Bacteriol. 2016;198(15):2113–2130.
- Antunes A, Camiade E, Monot M, et al. Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile. Nucleic Acids Res. 2012;40(21):10701–10718.
- Fujita Y. Carbon catabolite control of the metabolic network in Bacillus subtilis. Biosci Biotechnol Biochem. 2009;73(2):245–259.
- Kovacs AT. Bacterial differentiation via gradual activation of global regulators. Curr Genet. 2016;62(1):125–128.
- Carlson PE, Jr., Walk ST, Bourgis AE, et al. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe. 2013;24:109–116.
- Plaza-Garrido A, Miranda-Cardenas C, Castro-Cordova P, et al. Outcome of relapsing Clostridium difficile infections do not correlate with virulence-, spore- and vegetative cell-associated phenotypes. Anaerobe. 2015;36:30–38.
- Burns DA, Heeg D, Cartman ST, et al. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS One. 2011;6(9):e24894.
- Chilton CH, Pickering DS, Freeman J. Microbiologic factors affecting Clostridium difficile recurrence. Clin Microbiol Infect. 2018;24(5):476–482.
- Popham DL, Bernhards CB. Spore peptidoglycan. Microbiol Spectr. 2015;3(6):3.6.10.
- Fimlaid KA, Bond JP, Schutz KC, et al. Global analysis of the sporulation pathway of Clostridium difficile. PLoS Genet. 2013;9(8):e1003660.
- Saujet L, Pereira FC, Serrano M, et al. Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. PLoS Genet. 2013;9(10):e1003756.
- Janoir C, Deneve C, Bouttier S, et al. Adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect Immun. 2013;81(10):3757–3769.
- Pereira FC, Saujet L, Tome AR, et al. The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet. 2013;9(10):e1003782.
- Saujet L, Pereira FC, Henriques AO, et al. The regulatory network controlling spore formation in Clostridium difficile. FEMS Microbiol Lett. 2014;358(1):1–10.
- Pishdadian K, Fimlaid KA, Shen A. SpoIIID-mediated regulation of sigmaK function during Clostridium difficile sporulation. Mol Microbiol. 2015;95(2):189–208.
- Alves Feliciano C, Douche T, Giai Gianetto Q, et al. CotL, a new morphogenetic spore coat protein of Clostridium difficile. Environ Microbiol. 2019;21(3):984–1003.
- Permpoonpattana P, Phetcharaburanin J, Mikelsone A, et al. Functional characterization of Clostridium difficile spore coat proteins. J Bacteriol. 2013;195(7):1492–1503.
- Abhyankar W, Hossain AH, Djajasaputra A, et al. In pursuit of protein targets: proteomic characterization of bacterial spore outer layers. J Proteome Res. 2013;12(10):4507–4521.
- Diaz-Gonzalez F, Milano M, Olguin-Araneda V, et al. Protein composition of the outermost exosporium-like layer of Clostridium difficile 630 spores. J Proteomics. 2015;123:1–13.
- McKenney PT, Eichenberger P. Dynamics of spore coat morphogenesis in Bacillus subtilis. Mol Microbiol. 2012;83(2):245–260.
- McKenney PT, Driks A, Eskandarian HA, et al. A distance-weighted interaction map reveals a previously uncharacterized layer of the Bacillus subtilis spore coat. Curr Biol. 2010;20(10):934–938.
- Benito de la Puebla H, Giacalone D, Cooper A, et al. Role of SpoIVA ATPase motifs during Clostridioides difficile sporulation. J Bacteriol. 2020;202(21):e00387-20.
- Touchette MH, Benito de la Puebla H, Ravichandran P, et al. SpoIVA-SipL complex formation is essential for Clostridioides difficile spore assembly. J Bacteriol. 2019;201(8):e00042-19.
- Romero-Rodriguez A, Troncoso-Cotal S, Guerrero-Araya E, et al. The Clostridioides difficile cysteine-rich exosporium morphogenetic protein, CdeC, exhibits self-assembly properties that lead to organized inclusion bodies in Escherichia coli. mSphere. 2020;5(6):e01065-20.
- Kim H, Hahn M, Grabowski P, et al. The Bacillus subtilis spore coat protein interaction network. Mol Microbiol. 2006;59(2):487–502.
- Putnam EE, Nock AM, Lawley TD, et al. SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins. J Bacteriol. 2013;195(6):1214–1225.
- Ribis JW, Ravichandran P, Putnam EE, et al. The conserved spore coat protein SpoVM is largely dispensable in Clostridium difficile spore formation. mSphere. 2017;2(5):e00315-17.
- de Francesco M, Jacobs JZ, Nunes F, et al. Physical interaction between coat morphogenetic proteins SpoVID and CotE is necessary for spore encasement in Bacillus subtilis. J Bacteriol. 2012;194(18):4941–4950.
- Barra-Carrasco J, Olguin-Araneda V, Plaza-Garrido A, et al. The Clostridium difficile exosporium cysteine (CdeC)-rich protein is required for exosporium morphogenesis and coat assembly. J Bacteriol. 2013;195(17):3863–3875.
- Kim EY, Tyndall ER, Huang KC, et al. Dash-and-recruit mechanism drives membrane curvature recognition by the small bacterial protein SpoVM. Cell Syst. 2017;5(5):518–526 e3.
- Delerue T, Anantharaman V, Gilmore MC, et al. Bacterial developmental checkpoint that directly monitors cell surface morphogenesis. Dev Cell. 2022;57(3):344–360 e6.
- Wang KH, Isidro AL, Domingues L, et al. The coat morphogenetic protein SpoVID is necessary for spore encasement in Bacillus subtilis. Mol Microbiol. 2009;74(3):634–649.
- Pereira FC, Nunes F, Cruz F, et al. A LysM domain intervenes in sequential protein-protein and protein-peptidoglycan interactions important for spore coat assembly in Bacillus subtilis. J Bacteriol. 2019;201(4):e00642-18.
- Ramamurthi KS, Losick R. ATP-driven self-assembly of a morphogenetic protein in Bacillus subtilis. Mol Cell. 2008;31(3):406–414.
- Ebmeier SE, Tan IS, Clapham KR, et al. Small proteins link coat and cortex assembly during sporulation in Bacillus subtilis. Mol Microbiol. 2012;84(4):682–696.
- Touchette MH, Benito de la Puebla H, Alves Feliciano C, et al. Identification of a novel regulator of Clostridioides difficile cortex formation. mSphere. 2021;6(3):e0021121.
- Tan IS, Weiss CA, Popham DL, et al. A quality-control mechanism removes unfit cells from a population of sporulating bacteria. Dev Cell. 2015;34(6):682–693.
- Permpoonpattana P, Tolls EH, Nadem R, et al. Surface layers of Clostridium difficile endospores. J Bacteriol. 2011;193(23):6461–6470.
- Pizarro-Guajardo M, Ravanal MC, Paez MD, et al. Identification of Clostridium difficile immunoreactive spore proteins of the epidemic strain R20291. Proteomics Clin Appl. 2018;12(5):e1700182.
- Ghose C, Eugenis I, Edwards AN, et al. Immunogenicity and protective efficacy of Clostridium difficile spore proteins. Anaerobe. 2016;37:85–95.
- Basseres E, Endres BT, Montes-Bravo N, et al. Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores. Anaerobe. 2021;69:102352.
- Whittingham JL, Hanai S, Brannigan JA, et al. Crystal structures of the GH18 domain of the bifunctional peroxiredoxin-chitinase CotE from Clostridium difficile. Acta Crystallogr F Struct Biol Commun. 2020;76(Pt 6):241–249.
- Hong HA, Ferreira WT, Hosseini S, et al. The spore coat protein CotE facilitates host colonization by Clostridium difficile. J Infect Dis. 2017;216(11):1452–1459.
- Calderon-Romero P, Castro-Cordova P, Reyes-Ramirez R, et al. Clostridium difficile exosporium cysteine-rich proteins are essential for the morphogenesis of the exosporium layer, spore resistance, and affect C. difficile pathogenesis. PLoS Pathog. 2018;14(8):e1007199.